Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from FDA

Pharma-funded FDA gets drugs out faster, but some work only ‘marginally’ and most are pricey

Dr. Steven-Huy Han, a UCLA liver specialist, has prescribed Ocaliva to a handful of patients, although he’s not sure it helps.

Tribune News Service

Brie and camembert cheese recalled after listeria outbreak in six states

No deaths have been linked to listeria cases

The Independent UK

Why is corn syrup in infant formulas?

Nearly half of US infant formula contain corn sugars. Mounting evidence suggests it may not be the best for babies

Salon

From analysis to the latest developments in health,
read the most diverse news in one place.

ALS drug's approval draws cheers from patients, questions from skeptics

A controversial new drug for ALS could add months to patients' lives – if it actually works

WEKU

3 Safe Stocks You'll Want to Have Exposure to in 2022

The Fed’s aggressive monetary policies are raising recession fears. Amid such an environment, we think investors could consider adding AbbVie (ABBV), Pfizer (PFE), and Coca-Cola (KO) to their portfolios for stable returns. Read on to learn more….

StockNews.com

Intercept Pharmaceuticals Crashes After Drug Fails In Cirrhotic Patients

Intercept Pharmaceuticals' experimental NASH treatment failed in patients with liver cirrhosis, leading ICPT stock to plummet Friday.

Investors Business Daily

Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session

Gainers

Benzinga

Read news from The Economist, FT, and more,
with one subscription

US outlines plan for long-term baby formula imports

U.S. regulators have revealed their plan to allow foreign baby formula manufactures to stay on the market long term

The Independent UK

Highly Rated Amylyx Pharma Skids After Hard-Fought FDA Approval For ALS Drug

The Food and Drug Administration granted Amylyx Pharmaceuticals a hard-won approval in ALS treatment, but AMLX stock sank Friday.

Investors Business Daily

ALS drug wins FDA approval despite questionable data

U.S. health officials have approved a much-debated drug to treat the deadly illness known as Lou Gehrig's disease

The Independent UK

PharmaTher Provides Business Highlights And Releases Audited Annual Financials

PharmaTher Holdings Ltd. (OTCQB: PHRRF) has published its operational and audited financial results for fiscal year ended May 31, 2022.

Benzinga

FDA Admits Vaping Is Safer Than Smoking But Refuses To Correct the Record

Don’t expect a change in course, despite the long-awaited admission.

Reason

Civil service union urges honesty on public sector cuts amid austerity fears

Departments report being asked to find ways to reduce borrowing after Kwasi Kwarteng’s mini-budget

The Guardian - UK

Another prospect for an Alzheimer's drug renews cost concerns

But positive clinical trial results also renew the hopes of millions of seniors.

Axios

Get all your
news in one place.

100’s of premium titles.
One news app.

Tribune News Service

This company is bioengineering pig kidneys and livers for possible transplant into humans

In an Minnesota lab, clear containers hold pig kidneys and livers that scientists hope will someday be transplantable in humans.

Benzinga

These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win

Eli Lilly And Co (NYSE:LLY) - Market cap: $295 billion.

Benzinga

FDA Finally Advances Cannabis Research & Regulations: Hires Ex-NY Cannabis Policy Regulator

The FDA has appointed Norman Birenbaum to be the its senior public health advisor on cannabis research and regulatory actions,

Benzinga

7 Biogen Analysts On Alzheimer's Drug Success As Stock Skyrockets 37%

Shares of Biogen Inc (NASDAQ: BIIB) were flying on Wednesday, after the biopharma company said its experimental Alzheimer’s drug with Japanese partner Eisai showed promising results. RBC Capital Markets On Biogen

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Why MindMed Is Trading Lower By Around 35%; Here Are 31 Stocks Moving Premarket

Gainers Atlis Motor Vehicles Inc (NASDAQ: AMV) rose 211.7% to $256.00 in pre-market trading after jumping around 199% on Tuesday.

Daily Mirror

World's first EVER drug shown to work against Alzheimer's developed by scientists

Scientists say the development of the only drug to work against Alzheimer’s is a 'historic moment' - with regulators expected to approve the groundbreaking drug by the New Year

Benzinga

Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday

Gainers

Investors Business Daily

Dow Jones Futures Volatile On Bank Of England Reversal; Apple Falls On iPhone Report, Biogen Soars On Alzheimer's Drug

Apple is curbing iPhone production. The 10-year yield hit 4%, until the Bank of England stepped in. A Biogen Alzheimer's drug shows promise.

Tribune News Service

Stopgap funding measure back on track after Manchin concession on permitting

WASHINGTON — The path to averting a partial government shutdown by Friday night just became a little easier to see, after Senate Democrats said they'd drop a contentious environmental policy rider that had drawn critiques from the right and left.

The Independent UK

Starbucks customer stuns with 20 espresso shots order in one drink: ‘Is she ok?’

One Starbucks shot of espresso contains 75 milligrams of caffeine

Benzinga

Nasdaq Turns Higher; Crude Oil Rises Over 2%

U.S. stocks pared some losses toward the end of trading, with the Nasdaq Composite turning higher on Tuesday.

1 … 128 129 130 131

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.